Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis. Kalincik T, Horakova D, Spelman T, Jokubaitis V, Trojano M, Lugaresi A, Izquierdo G, Rozsa C, Grammond P, Alroughani R, et al. Ann Neurol. 2014 Dec 27. PMID: 25546031. Abstract CommentRecommendBookmarkWatch